Evidence map›Paper›PMID 42846182›Full record

ArticleJAACAP open2026

Relation Between Genotype and Behavioral Phenotype in Children and Adolescents With Neurofibromatosis Type 1.

Myrthe J Ottenhoff, Andre B Rietman, Daniela Gawehns, Mark Nellist, Shruti Garg, Julieta O'Flaherty, Susan J Kimber, Emma M M Burkitt Wright, Caroline Wouters, Ellen Denayer and 9 more

Abstract read
In one paragraph

Article in JAACAP open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Myrthe J OttenhoffErasmus MC Center of Expertise for Neurodevelopmental Disorders (ENCORE), Erasmus University Medical Center, Rotterdam, the Netherlands.
Andre B RietmanErasmus MC Center of Expertise for Neurodevelopmental Disorders (ENCORE), Erasmus University Medical Center, Rotterdam, the Netherlands.
Daniela GawehnsErasmus MC Center of Expertise for Neurodevelopmental Disorders (ENCORE), Erasmus University Medical Center, Rotterdam, the Netherlands.
Mark NellistErasmus MC Center of Expertise for Neurodevelopmental Disorders (ENCORE), Erasmus University Medical Center, Rotterdam, the Netherlands.
Shruti GargUniversity of Manchester, Manchester, United Kingdom.
Julieta O'FlahertyUniversity of Manchester, Manchester, United Kingdom.
Susan J KimberUniversity of Manchester, Manchester, United Kingdom.
Emma M M Burkitt WrightUniversity of Manchester, Manchester, United Kingdom.
Caroline WoutersUniversity Hospital Leuven, Leuven, Belgium.
Ellen DenayerFull Member of the European Reference Network on Genetic Tumour Risk Syndromes (ERN GENTURIS), Nijmegen, the Netherlands.
Rianne OostenbrinkErasmus MC Center of Expertise for Neurodevelopmental Disorders (ENCORE), Erasmus University Medical Center, Rotterdam, the Netherlands.
Pieter F A de NijsErasmus MC Center of Expertise for Neurodevelopmental Disorders (ENCORE), Erasmus University Medical Center, Rotterdam, the Netherlands.
Leontine W Ten HoopenErasmus MC Center of Expertise for Neurodevelopmental Disorders (ENCORE), Erasmus University Medical Center, Rotterdam, the Netherlands.
Marie-Claire Y de WitErasmus MC Center of Expertise for Neurodevelopmental Disorders (ENCORE), Erasmus University Medical Center, Rotterdam, the Netherlands.
Rick van MinkelenErasmus MC Center of Expertise for Neurodevelopmental Disorders (ENCORE), Erasmus University Medical Center, Rotterdam, the Netherlands.
Henriette A MollErasmus MC Center of Expertise for Neurodevelopmental Disorders (ENCORE), Erasmus University Medical Center, Rotterdam, the Netherlands.
Ype ElgersmaErasmus MC Center of Expertise for Neurodevelopmental Disorders (ENCORE), Erasmus University Medical Center, Rotterdam, the Netherlands.
Gwendolyn C DielemanErasmus MC Center of Expertise for Neurodevelopmental Disorders (ENCORE), Erasmus University Medical Center, Rotterdam, the Netherlands.
Sabine E MousErasmus MC Center of Expertise for Neurodevelopmental Disorders (ENCORE), Erasmus University Medical Center, Rotterdam, the Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Children with the autosomal dominant disorder neurofibromatosis 1 (NF1) exhibit a high prevalence of both attention-deficit/hyperactivity disorder (ADHD) (up to 40%) and autism (up to 11%). The genetic mechanisms underlying these behavioral phenotypes are largely unexplored. This study examines the associations between various Method: A retrospective cohort study was carried out in children and adolescents with NF1 from 3 national referral centers for NF1 (the Netherlands, United Kingdom, and Belgium). Anonymized data were collected on 5 primary outcomes to characterize the behavioral phenotype in NF1: autistic traits (Social Responsiveness Scale 2 Total T-score and Autism Diagnostic Observation Schedule Calibrated Severity Score), ADHD characteristics (Conners Inattention and Hyperactivity T-score), and global behavioral/emotional problems (Child Behavior Checklist Total Problems T-score). Genotypes were categorized based on 3 types of Results: In total, 408 children and adolescents with NF1 were included, of which 187 (46%) were girls. Range of median age at assessment across all outcomes was 6.0 to 8.4 years. Behavioral outcomes were not associated with any of the Conclusion: In this large cohort, autism traits, ADHD characteristics, or global behavioral/emotional problems were not associated with

Indexed as

attention-deficit/hyperactivity disorderautismgenotype–phenotype correlationneurofibromatosis type 1

Identifiers

PMID42846182
PMCPMC13643462

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.